These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 19768691)

  • 1. Nonparametric non-inferiority analyses in the three-arm design with active control and placebo.
    Munzel U
    Stat Med; 2009 Dec; 28(29):3643-56. PubMed ID: 19768691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing non-inferiority of a new treatment in a three-arm clinical trial including a placebo.
    Pigeot I; Schäfer J; Röhmel J; Hauschke D
    Stat Med; 2003 Mar; 22(6):883-99. PubMed ID: 12627407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-parametric assessment of non-inferiority with censored data.
    Freitag G; Lange S; Munk A
    Stat Med; 2006 Apr; 25(7):1201-17. PubMed ID: 16345041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the three-arm non-inferiority trial including a placebo with a prespecified margin.
    Hida E; Tango T
    Stat Med; 2011 Feb; 30(3):224-31. PubMed ID: 21213340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A note on the conservativeness of the confidence interval approach for the selection of non-inferiority margin in the two-arm active-control trial.
    Sankoh AJ
    Stat Med; 2008 Aug; 27(19):3732-42. PubMed ID: 18407575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A two-stage sample size recalculation procedure for placebo- and active-controlled non-inferiority trials.
    Schwartz TA; Denne JS
    Stat Med; 2006 Oct; 25(19):3396-406. PubMed ID: 16900573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tests of equivalence and non-inferiority for diagnostic accuracy based on the paired areas under ROC curves.
    Liu JP; Ma MC; Wu CY; Tai JY
    Stat Med; 2006 Apr; 25(7):1219-38. PubMed ID: 16158400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pairwise non-parametric non-inferiority tests in 3 x 3 cross-over trials: should we adjust for period?
    Duchateau L; Janssen P
    Stat Med; 2005 May; 24(10):1525-36. PubMed ID: 15761908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A group sequential type design for three-arm non-inferiority trials with binary endpoints.
    Li G; Gao S
    Biom J; 2010 Aug; 52(4):504-18. PubMed ID: 20645389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing non-inferiority of a new treatment in three-arm clinical trials with binary endpoints.
    Tang NS; Yu B; Tang ML
    BMC Med Res Methodol; 2014 Dec; 14():134. PubMed ID: 25524326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of thioctic acid in the therapy of peripheral diabetic neuropathy.
    Sachse G; Willms B
    Horm Metab Res Suppl; 1980; 9():105-7. PubMed ID: 6769773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-inferiority trials: design concepts and issues - the encounters of academic consultants in statistics.
    D'Agostino RB; Massaro JM; Sullivan LM
    Stat Med; 2003 Jan; 22(2):169-86. PubMed ID: 12520555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asthma management: the challenge of equivalence.
    Steinijans VW; Neuhäuser M; Hummel T; Leichtl S; Rathgeb F; Keller A
    Int J Clin Pharmacol Ther; 1998 Mar; 36(3):117-25. PubMed ID: 9562226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Methodological and statistical aspects of equivalence and non inferiority trials].
    Elie C; De Rycke Y; Jais JP; Marion-Gallois R; Landais P
    Rev Epidemiol Sante Publique; 2008 Aug; 56(4):267-77. PubMed ID: 18703296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combining stratified and unstratified log-rank tests in paired survival data.
    Oakes D; Feng C
    Stat Med; 2010 Jul; 29(16):1735-45. PubMed ID: 20572124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-inferiority trial design for recurrent events.
    Cook RJ; Lee KA; Li H
    Stat Med; 2007 Nov; 26(25):4563-77. PubMed ID: 17380542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active-controlled, non-inferiority trials in oncology: arbitrary limits, infeasible sample sizes and uninformative data analysis. is there another way?
    Carroll KJ
    Pharm Stat; 2006; 5(4):283-93. PubMed ID: 17128427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges and regulatory experiences with non-inferiority trial design without placebo arm.
    Hung HM; Wang SJ; O'Neill R
    Biom J; 2009 Apr; 51(2):324-34. PubMed ID: 19358213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A non-inferiority test for diagnostic accuracy based on the paired partial areas under ROC curves.
    Li CR; Liao CT; Liu JP
    Stat Med; 2008 May; 27(10):1762-76. PubMed ID: 17968858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A unifying approach to non-inferiority, equivalence and superiority tests via multiple decision processes.
    Hirotsu C
    Pharm Stat; 2007; 6(3):193-203. PubMed ID: 17879327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.